This site contains promotional content intended for Healthcare Professionals in Ireland and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Sign In
Don’t have an account?
  • Products
  • Therapy Area
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts
Bayer Logo
BAYERPROYour Resource Portal
  • Cardiology
  • Beyonttra®▼ (acoramidis)
  • Oncology
  • Nubeqa® (darolutamide)
  • Xofigo®▼ (radium-223 dichloride)
  • Women's Health
  • Jaydess® ▼ (13.5mg levonorgestrel)
  • Kyleena® (19.5mg levonorgestrel)
  • Mirena® (52mg levonorgestrel)
  • Qlaira® (estradiol valerate/dienogest)
  • Ophthalmology
  • Eylea® (aflibercept) 8mg
Products
  • Cardiology
  • Oncology
  • Ophthalmology
  • Women's Health
  • Cardiology Resources
  • Oncology Resources
  • Ophthalmology Resources
  • Women's Health Resources
  • Bayer Events & On Demand Webinars
  • Cardiology Events & On Demand Webinar
  • Oncology Events & On Demand Webinars
  • Ophthalmology Events & On Demand Webinars
  • Women's Health Events & On Demand Webinars
  • Cardiology Learning Zone
  • Oncology Learning Zone
  • Ophthalmology Learning Zone
  • Women's Health Learning Zone
  • Cardiology Podcasts
  • Oncology Podcasts
  • Ophthalmology Podcasts
closesearch
Recent Searches
    BayerPRO IRE Above Brand Header

    Ophthalmology: Resources

    EYLEA® (aflibercept) 8mg | Downloadable Resources

    Discover our HCP resources to learn more about EYLEA® (aflibercept) 8 mg

    EYLEA Prescribing Information
    PP-EYL_8mg-IE-0162-1, December 2025